📰 Forefront Analytics News
Page 9 - Forefront Analytics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Forefront Analytics. Real-time updates on events, politics, business and more.
October 8, 2023
StockNews.com assumed coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Free Report) in a research report released on Saturday morning. The firm issued a sell rating on the biotechnology company’s stock. Several other equities analysts also recently weighed in on EIGR. Citigroup reduced their target price on Eiger BioPharmaceuticals from $4.00 to $3.00 and set […]
September 21, 2023
Win Advisors Inc. purchased a new stake in shares of Invesco Dorsey Wright Momentum ETF (NASDAQ:PDP – Free Report) in the 2nd quarter, Holdings Channel reports. The institutional investor purchased 7,279 shares of the company’s stock, valued at approximately $467,000. Invesco Dorsey Wright Momentum ETF accounts for 0.6% of Win Advisors Inc.’s investment portfolio, making […]
September 14, 2023
Marotta Asset Management purchased a new position in Vanguard Emerging Markets Government Bond ETF (NASDAQ:VWOB – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 240,920 shares of the company’s stock, valued at approximately $15,002,000. Vanguard Emerging Markets Government Bond ETF […]
September 12, 2023
ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) has been given a consensus rating of “Buy” by the six ratings firms that are currently covering the stock, Marketbeat reports. Six analysts have rated the stock with a buy rating. The average 1-year price objective among brokers that have issued a report on the stock […]
August 30, 2023
Stonehage Fleming Financial Services Holdings Ltd trimmed its position in shares of iShares TIPS Bond ETF (NYSEARCA:TIP – Free Report) by 68.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,251 shares of the exchange traded fund’s stock after selling 7,158 shares […]
August 28, 2023
Forefront Analytics LLC boosted its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 14.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,009 shares of the healthcare product maker’s stock after acquiring an additional 383 shares during […]
August 28, 2023
Forefront Analytics LLC bought a new position in shares of iShares ESG Aware MSCI EAFE ETF (NASDAQ:ESGD – Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 273,342 shares of the company’s stock, valued at approximately $19,637,000. iShares […]
August 28, 2023
Forefront Analytics LLC boosted its stake in shares of iShares 20+ Year Treasury Bond ETF (NASDAQ:TLT – Free Report) by 8.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,803 shares of the exchange traded fund’s stock after purchasing an […]
August 28, 2023
Forefront Analytics LLC trimmed its position in shares of Vanguard Value ETF (NYSEARCA:VTV – Free Report) by 6.0% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 13,308 shares of the company’s stock after selling 847 shares during the period. Vanguard Value ETF accounts […]
August 28, 2023
Forefront Analytics LLC trimmed its holdings in shares of iShares Core High Dividend ETF (NYSEARCA:HDV – Free Report) by 7.1% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 70,573 shares of the exchange traded fund’s stock after selling 5,404 shares during the period. iShares Core High Dividend […]